• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
  • Home >
  • Back Issues >
  • Pharma Manufacturing >
  • May/June 2023

    • May/June 2023

    May/June 2023 Pharma Manufacturing
    Image

    Surrendering to the pharma magic

    July 17, 2023
    The science of ADCs makes for an incredible show
    Pm2306 Hero 854x480 Quality

    From paper errors to high-tech excellence

    July 6, 2023
    How pharma can use digital tools to modernize data integrity
    Shutterstock 359614955

    Drug packaging keeps pace

    July 5, 2023
    How future industry trends will influence pharma packaging needs
    Pm2306 Hero 854x480 Automation

    Transitioning to precision medicine

    June 27, 2023
    Moving away from one-size-fits-all treatments will require pharma to view data holistically
    Shutterstock 1664010940

    Engineering angles: Embracing BIM in pharma plant design

    June 26, 2023
    It’s time for the industry to overcome hesitations and utilize 3D technology

    More content from May/June 2023

    Pm2306 Hero 854x480 Operations

    Adapting drug delivery for distance-care

    June 22, 2023
    Advancements in patient-operated delivery systems offer safety and convenience
    Shutterstock 2025641213

    AI beyond drug development

    June 15, 2023
    How artificial intelligence can streamline pharma procurement and supply chain management
    Screen Shot 2023 06 14 At 12 13 06 Pm

    Spring pharma happenings: PDA’s Annual Meeting 2023

    June 14, 2023
    Through discussions that focused on innovative operational approaches as well as powerful patient-hosted sessions, the show sought to remind manufacturers to keep a patient-focused...
    Pm Article Option 4

    7 challenges of NGS-based biomarkers

    June 13, 2023
    Next generation sequencing has unprecedented power in biology, but has yet to reach its full potential in medicine
    Pm22 Hero 854x480 Act1 Cover Story

    The great reappearing act: ADCs' triumphant return

    June 9, 2023
    In our three-part series, we cover the trajectory of cancer-fighting ADCs in the pharma industry, including the modality’s history, obstacles and success stories
    Microsoft Teams Image (1)

    The great reappearing act: ADCs light up the stage

    June 9, 2023
    In the third and final part of our series on antibody-drug conjugates, we discuss the recent market buzz and the rise of new conjugated modalities.
    Pm22 Hero 854x480 Act2 Cover Story

    The great reappearing act: ADCs' new bag of tricks

    June 9, 2023
    In Act 2 of our series on antibody-drug conjugates, we cover improved linker and payload technology